跳转至内容
Merck
CN

CLS3474

Corning® Costar® 超低附着多孔板

size 96 well, flat bottom clear, pkg of (individually wrapped), pkg of (24/case), sterile, lid

别名:

96 well plate, 96多孔板, 96孔微孔板, 96孔微量滴定板, 组织培养板, 细胞培养板

登录 查看组织和合同定价。

选择尺寸

关于此项目

NACRES:
NB.13
UNSPSC Code:
41121800
Material:
clear
flat bottom clear
polystyrene
round wells
Size:
96 well

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

Corning® Costar® 超低附着多孔板, size 96 well, flat bottom clear, pkg of (individually wrapped), pkg of (24/case), sterile, lid

material

clear
flat bottom clear
polystyrene
round wells

sterility

sterile
sterile

feature

lid
lid
skirt
 plate format: standard
 well: flat bottom, clear

packaging

pack of 1 (individually wrapped w/ lid)
case of 24
pkg of (24/case)
pkg of (individually wrapped)

manufacturer/tradename

Corning 3474

size

96 well

surface area

0.32 cm2 , cell growth area (cm2)

well volume

360 μL

well working volume

75-200 μL

wells

96 wells

color

clear

suitability

suitable for (cell cuture)

binding type

(Ultra-Low Attachment)

正在寻找类似产品? 访问 产品对比指南

相关类别

General description

Corning Costar超低附着多孔板

  • 超低附着板具有共价结合的水凝胶层，可有效抑制细胞附着
  • 表面可最小化蛋白质吸收、酶活化和细胞活化
  • 表面无细胞毒性、具有生物惰性，不可降解
  • 带有冷凝环的不可逆盖子，可减少污染
  • 便于孔识别的单个字母数字代码
  • 均匀的底面，便于堆叠
  • 已通过γ辐射灭菌并已认证无热原

Legal Information

Corning is a registered trademark of Corning, Inc.
Costar is a registered trademark of Corning, Inc.

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Haitang Yang et al.
Cancers, 12(8) (2020-08-23)
Background: Malignant pleural mesothelioma (MPM) is driven by the inactivation of tumor suppressor genes (TSGs). An unmet need in the field is the translation of the genomic landscape into effective TSG-specific therapies. Methods: We correlated genomes against transcriptomes of patients'
Gianpaolo Zarletti et al.
Viruses, 12(11) (2020-11-12)
Knowledge of the antibody-mediated immune response to SARS-CoV-2 is crucial to understand virus immunogenicity, establish seroprevalence, and determine whether subjects or recovered patients are at risk for infection/reinfection and would therefore benefit from vaccination. Here, we describe a novel and
Shiny Amala Priya Rajan et al.
Acta biomaterialia, 106, 124-135 (2020-02-19)
Current drug development techniques are expensive and inefficient, partially due to the use of preclinical models that do not accurately recapitulate in vivo drug efficacy and cytotoxicity. To address this challenge, we report on an integrated, in vitro multi-organoid system

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持